Patent · US Active

Generating mature lineages from induced pluripotent stem cells with MECP2 disruption

US10961505B2 · kind B2 · utility

0Cited by
17References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 5, 2017
Grant dateMar 30, 2021
Priority date
Expiry dateOct 27, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided herein are methods for the efficient in vitro maintenance, expansion, culture, and/or differentiation of pluripotent cells with disruption of the MeCP2 gene into various erythroid, myeloid, lymphoid, or endoderm lineages, particularly mature erythrocytes. The pluripotent cells may be maintained and differentiated under defined conditions; thus, the use of mouse feeder cells or serum is not required in certain embodiments for the differentiation of the precursor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.